Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Choice of first-line agent critical in candidaemia

    This is a preview of subscription content, log in to check access.

    Rights and permissions

    Reprints and Permissions

    About this article

    Cite this article

    Choice of first-line agent critical in candidaemia. Pharmacoecon. Outcomes News 654, 5 (2012). https://doi.org/10.2165/00151234-201206540-00010

    Download citation

    Keywords

    • Fluconazole
    • Total Hospital Cost
    • Treatment Success Rate
    • Insurance Assessment
    • High Total Cost